Home - Products - Others - Other Targets - COH-SR4 (Mitochondria uncoupler SR4)

COH-SR4 (Mitochondria uncoupler SR4)

CAS No. 73439-19-7

COH-SR4 (Mitochondria uncoupler SR4) ( —— )

Catalog No. M22757 CAS No. 73439-19-7

SR4 is a uncoupler of mitochondrial oxidative phosphorylation. SR4 modulating amp-dependent kinase (ampk)-mammalian target of rapamycin (mtor) signaling, and inhibiting proliferation of hepg2 hepatocarcinoma cellsSR4 is a novel mitochondrial uncoupler with anti-obesity and anti-diabetic properties.?

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG 38 In Stock
50MG 52 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    COH-SR4 (Mitochondria uncoupler SR4)
  • Note
    Research use only, not for human use.
  • Brief Description
    SR4 is a uncoupler of mitochondrial oxidative phosphorylation. SR4 modulating amp-dependent kinase (ampk)-mammalian target of rapamycin (mtor) signaling, and inhibiting proliferation of hepg2 hepatocarcinoma cellsSR4 is a novel mitochondrial uncoupler with anti-obesity and anti-diabetic properties.?
  • Description
    SR4 is a uncoupler of mitochondrial oxidative phosphorylation. SR4 modulating amp-dependent kinase (ampk)-mammalian target of rapamycin (mtor) signaling, and inhibiting proliferation of hepg2 hepatocarcinoma cellsSR4 is a novel mitochondrial uncoupler with anti-obesity and anti-diabetic properties.?SR4 increased oxygen consumption, dissipated mitochondrial membrane potential, induced mitochondrial swelling, and decreased intracellular ATP in cultured cells and isolated liver mitochondria.?Oral feeding of SR4 significantly reduced body weight gain, improved glycemic control and insulin resistance, and prevented dyslipidemia in both high-fat-diet (HFD) induced obese and diabetic db/db mice.?SR4 treatment also decreased liver triglycerides and prevented hepatic steatosis in both animal models.?Mitochondrial uncoupling of SR4 results to activation of AMP-activated protein kinase (AMPK), leading to the phosphorylation and inhibition of acetyl-CoA carboxylase (ACC).?Gene analyses by RT-PCR showed SR4 significantly suppressed the mRNA expression of several lipogenic genes and gluconeogenic genes in the liver of HFD obese mice.?RNA sequencing analysis showed that 642 genes were differentially expressed in liver of db/db mice after SR4 treatment (217 upregulated, 425 down-regulated).?Gene ontology analysis by DAVID indicated SR4 upregulated amino acid metabolism and down-regulated lipid and fatty acid synthesis and glucose metabolism.?These studies demonstrate that SR4 may be a promising compound for treatment of T2DM and obesity.
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    73439-19-7
  • Formula Weight
    350.02
  • Molecular Formula
    C13H8Cl4N2O
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    Clc1cc(Cl)cc(NC(=O)Nc2cc(Cl)cc(Cl)c2)c1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Sharad S Singhal, James L Figarola, Jyotsana Singhal,et al.COH-SR4, a Novel Mitochondrial Uncoupler, Improves Metabolic Alterations in Obese and Diabetic Mice.
molnova catalog
related products
  • PTC299

    PTC299 (PTC-299) is a novel potent inhibitor of dihydroorotate dehydrogenase (DHODH), inhibits hypoxia-induced VEGFA protein production in HeLa cells with IC50 of 1.64 nM.

  • HCH6-1

    HCH6-1 is a competitive Formyl peptide receptor 1 (FPR1) antagonist.

  • 4'-Methoxypuerarin

    4'-Methoxypuerarin is a natural product isolated from Pueraria lobata.